Form 4: ALX Oncology Holdings Inc. Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Sophia Randolph, Chief Medical Officer of ALX Oncology Holdings Inc., sold 1,365 shares of common stock on August 14, 2024, to satisfy tax obligations related to vesting restricted stock units.
Summary
- On August 14, 2024, Sophia Randolph, the Chief Medical Officer of ALX Oncology Holdings Inc., sold 1,365 shares of the company's common stock.
- The shares were sold at a price of $2.58 per share.
- The transaction was executed to cover the reporting person's tax obligations associated with the vesting of restricted stock units.
- Following the transaction, Randolph directly owns 325,711 shares of ALX Oncology Holdings Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (sale of shares for tax obligations) and does not inherently indicate positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.
Stakeholder Impact
- The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial condition.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of transaction: Sophia Randolph sold 1,365 shares of ALX Oncology Holdings Inc. common stock. |
| 08/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.